Navigation Links
Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
Date:1/8/2009

ncer cells acquire multiple mutations that disable their normal response to apoptotic triggers. AEG35156, a second generation antisense which targets XIAP, is designed to lower the apoptotic threshold of cancer cells, enhancing their sensitivity to intrinsic death and chemotherapy, without harming healthy cells. Aegera's published data with AEG35156, both in vitro and in vivo, strongly supports this hypothesis, and validates XIAP as a novel drug target for the development of anti-cancer therapeutics.

About Aegera Therapeutics Inc.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing novel targeted therapies that address major unmet medical needs. In addition to AEG35156, Aegera has two additional programs in clinical development for the treatment of cancer and neuropathic pain. Details of these programs can be found on Aegera's website at www.aegera.com.


'/>"/>
SOURCE AEGERA THERAPEUTICS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Aegera Therapeutics phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting
2. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
3. Aegera Therapeutics welcomes two experienced executives to its board of directors
4. Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain
5. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
6. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
7. Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market
8. Horizon Therapeutics Announces Senior Management Appointments
9. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
10. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
11. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...NEW YORK, Nov. 9 "Micro cap and sm...to receive more broker sponsorship and exposure as...the upturn in commodity-driven stocks like gold, s...ident of The Haft Group, Inc, Manhattan based inve...and small cap equities market in the US and Canada...
(Date:11/9/2009)... SCHIEDLBERG, Austria, November 9 /PRNewswire/ ... world have been working on the development of a,B...mmunication channel,between the brain and a comput...ients to communicate or to control devices in thei...last years some patients have been supervised by,t...
(Date:11/9/2009)...VIENNA, Va., Nov. 9 CEL-... that Dr. Kenneth S. Rosenthal, Professor of Immun...sities College of Medicine and Pharmacy, reported ... at the Cleveland Clinic and CEL-SCI on CEL-SCI,s ...at the 7th GTCbio Vaccine: "All Things Considered"...
(Date:11/9/2009)... LONDON, November 9 Following t...e US Food and Drug Administration (FDA), privately...tp://www.davalinternational.com ) has been informe...PRO(R) has been awarded an Orphan-Drug,designation...s (ALS). , ALS, also known as Lou Gehrig,...
Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3
... UW Communications MILWAUKEE When the topic of ec...to mind is southeastern Wisconsin. With institutio... and the Milwaukee Area Technical College churni...story as a manufacturing center, the area seems to...ract big business. , ,However, factors such as th...
...te: This article is the first installment in a ser... , ,Source: Broadjam.com MADISON When the infam...he bubble for thousands of entrepreneurs who thoug...ept and standard business plan. Excessive spending...companies both novice and established to suffer,...
...etting all excited about the DSL line that deliver...good day) downstream. Foolish of me to be thrilled... wireless that reaches my coastal home. Until I he...ny,s Digital Media Business, I was delighted with ... Choi had a different opinion. , ,Broadband Intern...
Other Biology Technology:A cry for unity for the economy of southeast Wisconsin 2A cry for unity for the economy of southeast Wisconsin 3A cry for unity for the economy of southeast Wisconsin 4Online industry remains music to Broadjams ears 2Online industry remains music to Broadjams ears 3Online industry remains music to Broadjams ears 4Imagine the possibilites if you had very high-speed broadband 2Imagine the possibilites if you had very high-speed broadband 3Imagine the possibilites if you had very high-speed broadband 4
(Date:11/9/2009)...PHILADELPHIA Scientists and industry leaders from..., 2009, for the AACR-NCI-EORTC Molecular Targets a...hich will feature groundbreaking information on im...cer is a complex disease and to treat it effective... that takes place at the molecular level," said Le...
(Date:11/6/2009)...FAIRFAX, Va.Registration is now open for the Socie...erventional Oncology (IO) Therapies" Webinar, whic...and transcatheter treatment of liver tumors, kidne... national organization of physicians, scientists a...ing public health through pioneering advances in i...
(Date:11/5/2009)...The National Association of Biology Teachers (NABT...f biological sciences at Naugatuck Valley Communit...he 2009 Evolution Education Award during the NABT ...eld 11-14 November 2009 in Denver, Colorado. , T... American Institute of Biological Sciences,(AIBS)...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Biologists, educators recognize excellence in evolution education 2Study shows how normal cells influence tumor growth 59935 1Study shows how normal cells influence tumor growth 59935 2Radiation Treatments Made Safer for Cancer Patients 59930 1Radiation Treatments Made Safer for Cancer Patients 59930 2Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 1Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 2Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 3Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 4Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 5Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 6Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 7Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 8
...management is the key to regulating cell volume sa...the uptake and secretion of water by the plasma me...s the outcome of a subtle balance between water up...cell can regulate its volume by adjusting the salt...w this process works is still not known. Bas Tomas...
...ists at the Albert Einstein College of Medicine ha...ium that causes tuberculosis may soon be able to r...inolones. The finding explains why several disease... are rapidly becoming resistant to fluoroquinolone...Dr. John S. Blanchard, the Dan Danciger Professor ...
... latest version of the hide-and-seek game between ...ave found that a virus appears to cloak itself wit...vade detection and destruction by immune cells. ,...MI) researchers in an article published in the Jun...w how a virus uses the gene silencing machinery fo...
Other Biology News:Water management in cells 2Einstein researchers identify new way that bacteria develop resistance to antibiotics 2Virus uses tiny RNA to evade the immune system 2Virus uses tiny RNA to evade the immune system 3
...g of purified RNA samples., , This product has...NA samples that have been pre-purified using tradi...m, silica, oligo dT etc or other kits. , Our Sta... the stabilization of nanogram to milligram quanti...
...emplate is designed to allow kanamycin/neomycin se...ctively. It combines a prokaryotic promoter (gb2)... with a eukaryotic promoter (PGK) for expression ...okaryotic promoter gb2 is a slightly modified vers...
...nbach-style culture flask is designed for culturin...me ratio. It can also be used in serum production....ieve maximal oxygen transfer to culture medium. Be...ts cotton plugs or No. 13 rubber stoppers. This fl...
...a simple and efficient means for isolation of apop...gnetic beads (MagBeads). Annexin V is a Ca2+-depen...ty for phosphatidylseri The Apoptotic Cell Isolat...isolation of apoptotic cells or removal of dead ce...
Biology Products: